A Pilot Clinical Trial Assessing the Safety and Feasibility of Intramuscular Administration of the TA-CIN Vaccine as Adjuvant Therapy for Patients With History of HPV16 Associated Cervical Cancer
Phase of Trial: Phase I
Latest Information Update: 09 Nov 2018
At a glance
- Drugs Human papillomavirus vaccine (Primary)
- Indications Cervical cancer
- Focus Adverse reactions
- 29 Oct 2018 Status changed from not yet recruiting to recruiting.
- 31 Aug 2018 Biomarkers information updated
- 11 Jul 2018 Planned initiation date changed from 1 Jun 2018 to 1 Aug 2018.